Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZNTL Zentalis Pharmaceuticals, LLC

交易中 05-19 12:04:47 EDT

3.59

-0.04

-1.10%

最高3.65	最低3.48	成交量36.71万
今开3.59	昨收3.63	日振幅4.82%
总市值2.55亿	流通市值1.75亿	总股本7,093万
成交额131.11万	换手率0.75%	流通股本4,867万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZNTL","market":"US","secType":"STK","nameCN":"Zentalis Pharmaceuticals, LLC","latestPrice":3.59,"timestamp":1779206651529,"preClose":3.63,"halted":0,"volume":367149,"delay":0,"changeRate":-0.011019283746556485,"floatShares":48666300,"shares":70931016,"eps":-1.74,"marketStatus":"交易中","change":-0.04,"latestTime":"05-19 12:04:47 EDT","open":3.59,"high":3.65,"low":3.475,"amount":1311132.1088628,"amplitude":0.048209,"askPrice":3.59,"askSize":264,"bidPrice":3.58,"bidSize":560,"shortable":0,"etf":0,"ttmEps":-1.74,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1779220800000},"marketStatusCode":2,"adr":0,"listingDate":1585886400000,"exchange":"NASDAQ","adjPreClose":3.63,"preHourTrading":{"tag":"盘前","latestPrice":3.687,"preClose":3.63,"latestTime":"08:42 EDT","volume":474,"amount":1708.2851928,"timestamp":1779194521128,"change":0.057,"changeRate":0.015702,"amplitude":0.068871},"postHourTrading":{"tag":"盘后","latestPrice":3.63,"preClose":3.63,"latestTime":"17:37 EDT","volume":183,"amount":666.1512,"timestamp":1779140276825,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.593808,"impliedVol":4.5458,"impliedVolPercentile":0.9562},"requestUrl":"/m/hq/s/ZNTL/tweets","defaultTab":"tweets","newsList":[{"id":"1189092315","title":"Zentalis Pharmaceuticals宣布首位患者接受Azenosertib治疗 Cyclin E1阳性铂耐药卵巢癌的Aspenova三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1189092315","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189092315?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:01","pubTimestamp":1777982491,"startTime":"0","endTime":"0","summary":"Zentalis Pharmaceuticals, LLC宣布，其创新药物Azenosertib在针对Cyclin E1阳性铂耐药卵巢癌患者的Aspenova三期临床试验中，已完成首位患者的给药。这一重要进展标志着该试验正式启动，为卵巢癌治疗领域带来新的希望。Azenosertib作为一款潜在的重磅疗法，旨在针对特定基因异常的难治性卵巢癌患者群体。Cyclin E1阳性铂耐药卵巢癌目前治疗选择有限，临床需求迫切。Zentalis Pharmaceuticals专注于肿瘤创新药物的研发，此次进展体现了公司在卵巢癌治疗领域的持续投入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137777119","title":"Zentalis Pharmaceuticals宣布选定Azenosertib单药疗法400毫克每日一次（5:2方案）作为治疗周期蛋白E1阳性铂类耐药卵巢癌的关键研究剂量","url":"https://stock-news.laohu8.com/highlight/detail?id=1137777119","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137777119?lang=zh_cn&edition=full","pubTime":"2026-04-09 20:01","pubTimestamp":1775736069,"startTime":"0","endTime":"0","summary":"Zentalis Pharmaceuticals, LLC（纳斯达克代码：ZNTL）正式公布，其研发的Azenosertib单药疗法将以每日一次400毫克、采用用药五天休两天的给药方案，作为针对周期蛋白E1阳性铂类耐药卵巢癌患者开展关键性临床研究的确定剂量。这一决定基于前期临床试验数据，旨在优化疗效与安全性的平衡，为后续注册研究奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602858245","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨15.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602858245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602858245?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:31","pubTimestamp":1767969087,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时31分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价急速上涨15.72%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109223127a4b0cd2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109223127a4b0cd2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179876405","title":"Zentalis制药公司完成Denali试验2a阶段患者入组，剂量确认预计2026年上半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1179876405","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179876405?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:12","pubTimestamp":1767705134,"startTime":"0","endTime":"0","summary":"Zentalis制药公司宣布，其Denali临床试验的2a阶段患者入组工作已全部完成。该阶段旨在评估候选药物在特定患者群体中的安全性与初步疗效。公司计划于2026年上半年获得关键剂量确认数据，这将为后续临床开发提供重要依据。\n此次进展标志着Zentalis在肿瘤治疗领域迈出关键一步。若剂量确认结果积极，公司将加速推进后续研究，有望为患者提供新的治疗选择。行业观察人士正密切关注该项目的后续数据披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165944482","title":"Zentalis Pharmaceuticals公布企业动态，重点展望2026年Azenosertib研发项目关键里程碑与发展势头","url":"https://stock-news.laohu8.com/highlight/detail?id=1165944482","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165944482?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:03","pubTimestamp":1767704586,"startTime":"0","endTime":"0","summary":"Zentalis Pharmaceuticals, LLC近日发布企业最新进展，并着重介绍了其核心候选药物Azenosertib研发管线在2026年的重要规划节点与预期增长动能。公司明确勾勒出未来三年的战略路径，强调将持续推进Azenosertib在肿瘤治疗领域的临床开发，力争实现多项突破性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592153306","title":"Zentalis Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592153306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592153306?lang=zh_cn&edition=full","pubTime":"2025-12-19 02:34","pubTimestamp":1766082881,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日02时34分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.22%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121902344197a0773e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121902344197a0773e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584730968","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584730968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584730968?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:13","pubTimestamp":1763486035,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日01时13分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.30%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发 azenosertib ，这是一种潜在的同类首创和同类最佳 WEE1 抑制剂，用于 Cyclin E1 阳性铂耐药卵巢癌  患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119011355a7026363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119011355a7026363&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584961786","title":"Zentalis Pharmaceuticals, Inc.2025财年第三财季实现净利润-26.69百万美元，同比增加33.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584961786","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584961786?lang=zh_cn&edition=full","pubTime":"2025-11-17 00:01","pubTimestamp":1763308914,"startTime":"0","endTime":"0","summary":"11月17日，Zentalis Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第三财季净利润为-26.69百万美元，同比增加33.54%；其中营业收入为0.00美元，每股基本收益为-0.37美元。从资产负债表来看，Zentalis Pharmaceuticals, Inc.总负债74.38百万美元，其中短期债务3.75百万美元，资产负债比为0.05，流动比率为0.08。机构评级：截至2025年11月17日，当前有7家机构对Zentalis Pharmaceuticals, Inc.目标价做出预测，其中目标均价为5.71美元，其中最低目标价为2.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000208a6fd6ce1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000208a6fd6ce1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518207806","title":"Zentalis Pharmaceuticals, Inc.盘中异动 下午盘大幅跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518207806?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:06","pubTimestamp":1741633597,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时06分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.22%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6198.70%、3856.84%、1019.75%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103063898a2dd03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103063898a2dd03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516965807","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516965807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516965807?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:59","pubTimestamp":1741017580,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时59分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.07%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3033.12%、143.00%、135.18%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235940abe65071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235940abe65071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514876334","title":"Zentalis Pharmaceuticals, Inc.盘中异动 下午盘急速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514876334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514876334?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:38","pubTimestamp":1740685081,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时38分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.12%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Pepgen Inc.、Alpha Tau Medical Ltd C/Wts 、Ibio, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1906.62%、331.29%、184.15%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280338029632e97b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280338029632e97b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514697015","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅下挫5.17%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514697015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514697015?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:17","pubTimestamp":1740496641,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时17分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.17%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1050.17%、843.02%、585.87%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、63.66%、61.16%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231721a2539278&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231721a2539278&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513031291","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513031291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513031291?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:28","pubTimestamp":1740151686,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时28分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.23%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为168.90%、107.65%、99.97%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为67.41%、57.50%、48.19%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221232807abd7bc32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221232807abd7bc32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512484008","title":"Zentalis Pharmaceuticals, Inc.盘中异动 临近午盘大幅拉升5.04%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512484008?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:30","pubTimestamp":1739982632,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时30分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.04%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为586.69%、244.62%、197.13%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003032a24c1207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003032a24c1207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512216441","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512216441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512216441?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:56","pubTimestamp":1739894173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时56分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.35%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Allogene Therapeutics, Inc.、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为378.65%、170.66%、142.62%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235613a24abf99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218235613a24abf99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511669959","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.35%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511669959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511669959?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544497,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.35%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1826.44%、480.21%、417.95%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422481796231f53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422481796231f53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511657526","title":"Zentalis Pharmaceuticals, Inc.盘中异动 急速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511657526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511657526?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457062,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.09%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.14%、764.83%、89.76%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Aim Immunotech Inc.、Aditxt, Inc.，振幅分别为6.98%、5.37%、3.84%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223102abcdb1d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223102abcdb1d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380143","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380143?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:40","pubTimestamp":1739284823,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时40分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.10%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2234.52%、582.78%、227.77%，振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.，振幅分别为32.43%、31.80%、29.38%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112240249881bed7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112240249881bed7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","OCEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865913","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速上涨5.21%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510865913?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:51","pubTimestamp":1739199117,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时51分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.21%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2180.85%、1376.40%、783.29%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为59.71%、46.20%、39.13%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225158abc9aaaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225158abc9aaaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509877662","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨10.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509877662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509877662?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765913,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅拉升10.42%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为2582.78%、594.69%、580.21%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Eyepoint Pharmaceuticals, Inc.、Oragenics Inc.，振幅分别为13.94%、11.42%、9.75%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223153abc37d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223153abc37d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","ZNTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zentalis.com;ir.zentalis.com","stockEarnings":[{"period":"1week","weight":-0.1232},{"period":"1month","weight":-0.2177},{"period":"3month","weight":0.5381},{"period":"6month","weight":1.7293},{"period":"1year","weight":1.881},{"period":"ytd","weight":1.6889}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zentalis Pharmaceuticals, Inc.于2014年12月23日在特拉华州以Zeno Pharmaceuticals，Inc.的身份注册成立。Zentalis Pharmaceuticals，Inc.是一家临床阶段制药公司，致力于发现和开发针对癌症基本生物途径的临床分化的新型小分子疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.042332},{"month":2,"riseRate":0.5,"avgChangeRate":0.033871},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.05504},{"month":4,"riseRate":0.5,"avgChangeRate":0.088542},{"month":5,"riseRate":0.428571,"avgChangeRate":0.050271},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.096016},{"month":7,"riseRate":0.5,"avgChangeRate":-0.025772},{"month":8,"riseRate":0.333333,"avgChangeRate":0.051305},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.092542},{"month":10,"riseRate":0.5,"avgChangeRate":0.021215},{"month":11,"riseRate":0.5,"avgChangeRate":0.025361},{"month":12,"riseRate":0.5,"avgChangeRate":0.014046}],"exchange":"NASDAQ","name":"Zentalis Pharmaceuticals, LLC","nameEN":"Zentalis Pharmaceuticals, LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zentalis Pharmaceuticals, LLC,ZNTL,Zentalis Pharmaceuticals, LLC股票,Zentalis Pharmaceuticals, LLC股票老虎,Zentalis Pharmaceuticals, LLC股票老虎国际,Zentalis Pharmaceuticals, LLC行情,Zentalis Pharmaceuticals, LLC股票行情,Zentalis Pharmaceuticals, LLC股价,Zentalis Pharmaceuticals, LLC股市,Zentalis Pharmaceuticals, LLC股票价格,Zentalis Pharmaceuticals, LLC股票交易,Zentalis Pharmaceuticals, LLC股票购买,Zentalis Pharmaceuticals, LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}